Interleukin-12 is necessary for the priming of CD4+ T cells required during the elicitation of HIV-1 gp120-specific cytotoxic T-lymphocyte function

Immunology

Volumn 124, Issue 4, 2008, Pages 553-561

  Gupta, Shalini ^a   Boppana, Ramanamurthy ^a   Mishra, Gyan C ^a   Saha, Bhaskar ^a   Mitra, Debashis ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

Author keywords

Cytokine; Cytotoxic T lymphocytes; gp120; Human immunodeficiency virus 1; Interleukin 12

Indexed keywords

COMPLEMENTARY DNA; DNA; GAMMA INTERFERON; GLYCOPROTEIN GP 120; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DNA IMMUNIZATION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; INTERLEUKIN-12; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; T-LYMPHOCYTES, CYTOTOXIC;

EID: 46949088296     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2008.02809.x     Document Type: Article

References (46)

1. Andersen MH, Schrama D, Thor SP, Becker JC. Cytotoxic T cells. J Invest Dermatol 2006 126 : 32 41.
2. Nagata S. Fas-mediated apoptosis. Adv Exp Med Biol 1996 406 : 119 24.
3. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 1994 76 : 977 87.
4. Trapani JA, Smyth MJ. Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol 2002 2 : 735 47.
5. Trapani JA, Sutton VR. Granzyme B: pro-apoptotic, antiviral and antitumor functions. Curr Opin Immunol 2003 15 : 533 43.
6. + lymphocytes. Science 1999 283 : 857 60.
7. Valdez H, Lederman MM. Cytokines and cytokine therapies in HIV infection. AIDS Clin Rev 1997 187 : 187 228.
8. Shearer GM, Levy RB. Noninfectious cofactors in susceptibility to AIDS: possible contributions of semen, HLA alloantigens, and lack of natural resistance. Ann N Y Acad Sci 1984 437 : 49 57.
9. Lee BN, Lu JG, Kline MW, Paul M, Doyle M, Kozinetz C, Shearer WT, Reuben JM. Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus. Clin Diagn Lab Immunol 1996 3 : 493 9.
10. Greenwald RJ, Freeman GJ, Sharpe AH. The B7 family revisited. Annu Rev Immunol 2005 23 : 515 48.
11. Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 1998 393 : 480 3.
12. O'Sullivan B, Thomas R. CD40 and dendritic cell function. Crit Rev Immunol 2003 23 : 83 107.
13. Rockstroh JK, Kruezer KA, Sauerbruch T, Spengler U. Protein levels of interleukin-12 p70 holomer, its p40 chain and interferon-gamma during advancing HIV infection. J Infect 1998 37 : 282 6.
14. Vanham G, Penne L, Devalck J, Kestens L, Colebunders R, Bosmans E, Thielemans K, Ceuppens JL. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol 1999 117 : 335 42.
15. Marshall JD, Chehimi J, Gri G, Kostman JR, Montaner LJ, Trinchieri G. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals. Blood 1999 94 : 1003 11.
16. Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, Helm EB, Hoelzer D, Rossol R. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997 11 : 1111 8.
17. Oxenius A, Karrer U, Zinkernagel RM, Hengartner H. IL-12 is not required for induction of type 1 cytokine responses in viral infections. J Immunol 1999 162 : 965 73.
18. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997 186 : 39 45.
19. Wang S, Pal R, Mascola JR et al. Polyvalent HIV-1 Env vaccine formulations delivered by the DNA priming plus protein boosting approach are effective in generating neutralizing antibodies against primary human immunodeficiency virus type 1 isolates from subtypes A, B, C, D and E. Virology 2006 350 : 34 47.
20. Calarota S, Bratt G, Nordlund S, Hinkula J, Leandersson AC, Sandstrom E, Wahren B. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 1998 351 : 1320 5.
21. Lole KS, Bollinger RC, Paranjape RS et al. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999 73 : 152 60.
22. Morikawa Y, Overton HA, Moore JP, Wilkinson AJ, Brady RL, Lewis SJ, Jones MI. Expression of HIV-1 gp120 and human soluble CD4 by recombinant baculoviruses and their interaction in vitro. AIDS Res Hum Retroviruses 1990 6 : 765 73.
23. Wang YH, Davies AH, Jones IM. Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26. Virology 1995 208 : 142 6.
24. Michell BE, Shiigi SM (eds). Preparation of mouse cell suspension. In : Selected Method in Cellular Immunology. New York : W.H. Freeman and company, 1980 : 23 4.
25. Matzinger P. The JAM test. A simple assay for DNA fragmentation and cell death. J Immunol Methods 1991 145 : 185 92.
26. Ang OO, Lin H, Dagarag M, Ng HL, Effros RB, Uittenbogaart CH. Decreased perforin and granzyme B expression in senescent HIV-1-specific cytotoxic T lymphocytes. Virology 2005 332 : 16 9.
27. + T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 2000 192 : 63 75.
28. Wodarz D, Jansen VA. The role of T cell help for anti-viral CTL responses. J Theor Biol 2001 211 : 419 32.
29. + T cells: when, where, and how. Annu Rev Immunol 2006 24 : 519 40.
30. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, Trinchieri G. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J Exp Med 1994 179 : 1361 6.
31. Chougnet C, Wynn TA, Clerici M et al. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus. J Infect Dis 1996 174 : 46 53.
32. + T cell proliferation and IL-2 production by highly enriched populations of HIV-infected dendritic cells. J Immunol 2003 170 : 4260 6.
33. Bailer RT, Holloway A, Sun J, Margolick JB, Martin M, Kostman J, Montaner LJ. IL-13 and IFN-γ secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression. J Immunol 1999 162 : 7534 42.
34. Kostense S, Vandenberghe K, Joling J, Van Baarle D, Nanlohy N, Manting E, Miedema F. Persistent numbers of tetramer+ CD8(+) T cells, but loss of interferon-gamma+ HIV-specific T cells during progression to AIDS. Blood 2002 99 : 2505 11.
35. Boyer JD, Cohen AD, Ugen KE et al. Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. AIDS 2000 14 : 1515 22.
36. + T cells from late stage patients on prolonged antiretroviral therapy by stimulation in vitro with HIV-1 protein loaded dendritic cells. J Virol 2001 75 : 4413 9.
37. Hodge-Dufour J, Marino MW, Horton MR. et al. Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci U S A 1998 95 : 13806 11.
38. Kennedy M, Picha KS, Fanslow WC, Grabstein KH, Alderson MR, Clifford KN, Chin WA, Mohler KM. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages. Eur J Immunol 1996 26 : 370 8.
39. Kelsall BL, Stuber E, Neurath M, Strober W. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses. Ann N Y Acad Sci 1996 795 : 116 26.
40. Stuber E, Strober W, Neurath M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J Exp Med 1996 183 : 693 8.
41. Vanham G, Penne L, Devalck J, Kestens L, Colebunders R, Bosmans E, Thielemans K, Ceuppens JL. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection. Clin Exp Immunol 1999 117 : 335 42.
42. + T cells independently of IL-12. J Immunol 2004 173 : 2443 52.
43. Jacobson MA, Hardy D, Conninck E, Watson J, Debruin M. Phase I trial of a single dose of recombinant human interleukin-12 in human immunodeficiency virus infected patients with 100-500 CD4 cells/microL. J Infect Dis 2000 182 : 1070 6.
44. Jacobson MA, Spritzler J, Landay A et al. AACTG 325 protocol team. A phase I, placebo-controlled trial of multi-dose recombinant human interleukin-12 in patients with HIV infection. AIDS 2002 16 : 1147 54.
45. Little RF, Pluda JM, Wyvill KM, Rodriguez-Chavez IR, Tosato G, Catanzaro AT, Steinberg SM, Yarchoan R. Activity of subcutaneous interleukin-12 in AIDS related Kaposi sarcoma. Blood 2006 107 : 4650 7.
46. Salazar-Gonzalez JF, Martinez-Maza O, Nishanian P et al. Increased immune activation precedes the inflection point of CD4 T cells and the increased serum virus load in human immunodeficiency virus infection. J Infect Dis 1998 178 : 423 43.